As a global leader in sustainable technologies, we apply our cutting-edge science to create solutions with our customers that make a real difference to the world around us.
We’ve been leaders in our field for more than 200 years, applying unrivalled scientific expertise to enable cleaner air, improved health and the more efficient use of our planet's natural resources.
And our story doesn’t end there. Through continued investment in sound research and development, we’re tackling the world’s big challenges into our third century and beyond.
Single-crystal x-ray diffraction (SCXRD) in drug development is evolving. Johnson Matthey outlines how technology advances and regulations are reshaping its role in pharma
Enzymes have evolved into nature’s reaction facilitators over millions of years and their unique catalytic abilities drive science by connecting essential life elements
A recent study suggests that around 40% of drugs with market approval exhibit poor water solubility and although this is not a new problem, solutions like those offered by Johnson Matthey are still relevant to today’s pharma market
The elements of future power